Advanced search
Publication Cover
Blood Pressure Volume 17, 2008 - Issue sup1
Submit an article Journal homepage
410
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Combination therapy with valsartan/hydrochlorothiazide at doses up to 320/25 mg improves blood pressure levels in patients with hypertension inadequately controlled by valsartan 320 mg monotherapy

Jaakko Tuomilehto Deparment of Public Health, University of Helsinki, Mannerheimintie 172, FIN‐00300, Helsinki, Finland; South Ostrobothnia Central Hospital, FIN‐60220 Seinäjoki, Finland
,
Andrzej Tykarski Poznan University of Medical Sciences, Department of Hypertension, Angiology and Internal Diseases, Poznan, Poland
,
Peter Baumgart Clemenshospital GmbH, Düesbergweg 124, 48153 Münster, Germany
,
Bernard Reimund Novartis Pharma AG, Basel, Switzerland
,
Stephanie Le Breton Novartis Pharma AG, Basel, Switzerland
&
Philippe Ferber Novartis Pharma AG, Basel, SwitzerlandCorrespondence[email protected]
Pages 15-23 | Published online: 08 Jul 2009

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Roberto Fogari & Annalisa Zoppi. (2011) A drug safety evaluation of valsartan. Expert Opinion on Drug Safety 10:2, pages 295-303.
Read now
Maurizio Destro, Nora Crikelair, Joseph Yen & Robert Glazer. (2010) Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients. Vascular Health and Risk Management 6, pages 821-827.
Read now

Articles from other publishers (5)

Mengxin Xie, Tianjiao Tang & Hongsheng Liang. (2023) Efficacy of single‐pill combination in uncontrolled essential hypertension: A systematic review and network meta‐analysis. Clinical Cardiology.
Crossref
Linlin Ma, Keyang Zheng, Jiafu Yan & Wenli Cheng. (2021) Efficacy of ARB/HCTZ Combination Therapy in Uncontrolled Hypertensive Patients Compared with ARB Monotherapy: A Meta-Analysis. International Journal of Hypertension 2021, pages 1-7.
Crossref
D. Richter, C. Mickel, S. Acharya, P. Brunel & C. Militaru. (2011) Aliskiren-based stepped-care treatment algorithm provides effective blood pressure control. International Journal of Clinical Practice 65:5, pages 613-623.
Crossref
Gianfranco Parati, Roland Asmar, Grzegorz Bilo, Albert Kandra, Robert Di Giovanni & Thomas Mengden. (2010) Effectiveness and safety of high-dose valsartan monotherapy in hypertension treatment: the ValTop study. Hypertension Research 33:10, pages 986-994.
Crossref
David A. Calhoun, Nora A. Crikelair, Joseph Yen & Robert D. Glazer. (2009) Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety. Advances in Therapy 26:11, pages 1012-1023.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.